United Kingdom Peripheral Vascular Devices Market Size, Share, and COVID-19 Impact Analysis, By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and United Kingdom Peripheral Vascular Devices Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Peripheral Vascular Devices Market Insights Forecasts to 2035

• The United Kingdom Peripheral Vascular Devices Market Size Was Estimated at USD 447.18 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.01% from 2025 to 2035
• The United Kingdom Peripheral Vascular Devices Market Size is Expected to Reach USD 942.28 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Peripheral Vascular Devices Market is anticipated to reach USD 942.28 million by 2035, growing at a CAGR of 7.01% from 2025 to 2035. The increased healthcare spending, aging populations, improvements in minimally invasive procedures, and a rising incidence of cardiovascular illnesses.  Further bolstering market expansion are improved diagnostic tools and rising awareness of early treatment.

Market Overview

The United Kingdom peripheral vascular devices market refers to the industry focused on medical devices that identify and treat peripheral vascular diseases, which affect blood vessels outside the heart and brain, particularly those in the limbs.  These tools include atherectomy systems, angioplasty balloons, catheters, and stents. The aging population, an increase in cardiovascular cases, and developments in minimally invasive technologies are driving the industry, which promotes improved outcomes for patients and effective management of vascular disease. The rising incidences of diabetes and peripheral vascular disease, in addition to a population that is aging rapidly. Technological developments in imaging techniques and minimally invasive technologies are fueling demand. Favorable conditions for market participants to innovate and broaden their offers across hospitals and specialist clinics are further created by supported government programs for early diagnosis and treatment, increased patient awareness, and expanded access to healthcare services. Bioresorbable stents that disintegrate once blood flow is restored, drug-coated balloons that lessen restenosis, and imaging-enabled atherectomy tools for accurate plaque removal.  AI-guided robotic catheter systems are also becoming more popular, improving procedure precision and reducing complications associated with vascular procedures.

Report Coverage

This research report categorizes the market for the United Kingdom peripheral vascular devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom peripheral vascular devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom peripheral vascular devices market.

Driving Factors

The demand for efficient treatment options is developing sharply as a consequence of the increased incidence of peripheral arterial disease (PAD), which is primarily brought on by age, diabetes, and obesity. Adoption is being aided by improvements in patient outcomes and recovery times brought about by advancements in minimally invasive procedures, such as drug-coated balloons and bioresorbable stents. A strong medical infrastructure, encouraging government policies, and rising healthcare spending all contribute to market expansion. Peripheral vascular devices are additionally growing more and more common in clinics and hospitals due to improved imaging technology, increased patient awareness, and early diagnosis.

Restraining Factors

The expensive gadget prices, difficult regulatory approval procedures, and potential issues with the process.  Further impeding general adoption and market expansion are low knowledge of peripheral artery disease, particularly in its early stages, a lack of qualified experts, and NHS financial limitations.

Market Segmentation

The United Kingdom peripheral vascular devices market share is classified into type and end-user.

• The angioplasty stents segment accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.  

The United Kingdom peripheral vascular devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, the angioplasty stents segment accounted for the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by the growing adoption of minimally invasive procedures, the rise in peripheral artery disease brought on by aging and lifestyle factors, and advancements in drug-eluting and bioresorbable stent designs.

• The hospitals segment accounted for the highest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom peripheral vascular devices market is segmented by end-user into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospitals segment accounted for the highest revenue in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth can be attributed to growing demand for minimally invasive therapies, the availability of sophisticated medical infrastructure, qualified personnel, and an increase in PAD cases.  Growth in this market is additionally supported by increased patient influx and government backing.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom peripheral vascular devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Becton, Dickinson and Company
• Biotronik SE and Co. KG
• Koninklijke Philips N.V.
• Boston Scientific Corporation
• Terumo Corporation
• Cook Medical
• Straub Medical AG
• Eurocor Tech GmbH
• AngioDynamics, Inc.
• Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at UK, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom peripheral vascular devices market based on the below-mentioned segments:

United Kingdom Peripheral Vascular Devices Market, By Type

• Angioplasty Balloons
• Angioplasty Stents
• Catheters
• Guidewires
• Others

United Kingdom Peripheral Vascular Devices Market, By End-user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics